FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca 2 min read BUSINESS FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca IndiaNews12 June 9, 2025 The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial... Read More Read more about FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
